Hepatocellular Carcinoma: Molecular Biology and Therapy
![Thumbnail](/xmlui/bitstream/handle/10234/187795/GhassanA_Hepatocellular_Carcicoma.pdf.jpg?sequence=5&isAllowed=y)
Visualitza/
Metadades
Mostra el registre complet de l'elementcomunitat-uji-handle:10234/12
comunitat-uji-handle2:10234/182887
comunitat-uji-handle3:
comunitat-uji-handle4:
BIBLIOMetadades
Títol
Hepatocellular Carcinoma: Molecular Biology and TherapyAutoria
Data de publicació
2007Resum
Advanced and metastatic hepatocellular carcinomas (HCC) are challenging to treat, and no cytotoxic agents have impacted survival. The underlying liver cirrhosis that commonly accompanies HCC provides an additional ... [+]
Advanced and metastatic hepatocellular carcinomas (HCC) are challenging to treat, and no cytotoxic agents have impacted survival. The underlying liver cirrhosis that commonly accompanies HCC provides an additional challenge; indeed, functional scoring of cirrhosis and HCC is a critical component of patient evaluation. Currently, the molecular biology and pathogenesis of HCC are being increasingly investigated, which may lead to better understanding of the evolution of the disease, especially differing etiologies and identification of survival genes that may affect outcome. Early studies of targeted therapies in HCC have shown disease stabilization, and an increased understanding of the mechanism(s) of these novel agents combined with correlative studies may lead to the identification of an active agent or combination of agents that impacts the natural history of HCC. [-]
Tipus de document
info:eu-repo/semantics/articleVersió de l'editorial
Seminars in Oncology 2006; 33 (Supl. 11): S79-83Drets d'accés
info:eu-repo/semantics/openAccess
Apareix a les col.leccions
Els següents fitxers sobre la llicència estan associats a aquest element: